Kasaian M T, Clay M J, Happ M P, Garman R D, Hirani S, Luqman M
ImmuLogic Pharmaceutical Corp., Waltham, MA 02154, USA.
Int Immunol. 1996 Aug;8(8):1287-97. doi: 10.1093/intimm/8.8.1287.
As a potent inducing agent for IgE production and differentiation factor for allergen-specific Th2 cells, IL-4 is a key regulatory cytokine both in the pathogenesis of allergic disease and in the ongoing allergic response. The assay of in vitro IL-4 production has often been used to compare the allergen responses of T cells isolated from atopic and non-atopic subjects. Because peripheral blood basophils also have the capacity to respond to specific allergen by producing IL-4, we investigated the relative contribution of these two cell types to IL-4 production in allergen-stimulated primary cultures. Among unfractionated peripheral blood mononuclear cells (PBMC), the major producers of detectable IL-4 in primary in vitro cultures were found to be basophils based on: (i) an allergen dose-response corresponding closely to that required for basophil histamine release and lower than that required for T cell activation; (ii) a rapid time course for IL-4 production (detectable at 3 h), inconsistent with the typical activation requirements of fresh T cells; (iii) the production of comparable levels of IL-4 in cultures stimulated with allergen or anti-IgE; and (iv) the complete loss of detectable IL-4 production following specific depletion of basophils from PBMC. The T cells in these cultures were functionally able to produce IL-4, as demonstrated by mitogen activation of basophil-depleted PBMC. These findings demonstrate that although IL-4 production in primary in vitro cultures can be used as a sensitive indicator of allergen responsiveness, the accurate interpretation of this result requires identification of the responding cell type. Furthermore, these findings raise the possibility that basophil production of IL-4 early in the course of allergen stimulation may shape subsequent T cell responses both in vivo and in vitro.
作为一种诱导IgE产生的强效因子以及变应原特异性Th2细胞的分化因子,白细胞介素-4(IL-4)在变应性疾病的发病机制以及持续的变应性反应中均是一种关键的调节性细胞因子。体外IL-4产生的检测常被用于比较从特应性和非特应性受试者分离出的T细胞的变应原反应。由于外周血嗜碱性粒细胞也有通过产生IL-4来对特异性变应原作出反应的能力,我们研究了这两种细胞类型在变应原刺激的原代培养物中对IL-4产生的相对贡献。在未分离的外周血单个核细胞(PBMC)中,基于以下几点发现原代体外培养物中可检测到的IL-4的主要产生者是嗜碱性粒细胞:(i)变应原剂量反应与嗜碱性粒细胞组胺释放所需的剂量反应密切对应且低于T细胞活化所需的剂量反应;(ii)IL-4产生的快速时间进程(3小时可检测到),这与新鲜T细胞的典型活化要求不一致;(iii)在变应原或抗IgE刺激的培养物中产生相当水平的IL-4;以及(iv)从PBMC中特异性去除嗜碱性粒细胞后可检测到的IL-4产生完全丧失。这些培养物中的T细胞在功能上能够产生IL-4,嗜碱性粒细胞去除的PBMC的丝裂原活化证明了这一点。这些发现表明,虽然原代体外培养物中IL-4的产生可作为变应原反应性的敏感指标,但对该结果的准确解释需要鉴定反应细胞类型。此外,这些发现增加了一种可能性,即变应原刺激过程早期嗜碱性粒细胞产生的IL-4可能在体内和体外塑造随后的T细胞反应。